The Effect of Partnership Care Model on Anxiety of Adolescent with β-Thalassemia

Abstract

Background: Beta-thalassemia major (TM) is a chronic, genetically determined hematological disorder and affects different aspects of patient's psychological life. Objectives: This study was designed to examine the impact of partnership care model on anxiety of adolescent with β-thalassemia in 2013. Materials and Methods: This quasi-experimental study was performed by selecting 60 adolescent with β-thalassemia. Patients were randomly allocated into two groups of tests and control groups (each group included 30 patients) in Shahid Dastgheyb Hospital of Shiraz. The partnership care model, which consisted of four main steps of orientation, sensitization, control and evaluation, was performed for the experimental group. Data collection tool was Depression Anxiety Stress Scale (DASS-21) questionnaire that assessed adolescents’ anxiety before and after 3 months, which was completed by both groups. The data were analyzed using SPSS v.16 by chi-square test, paired T-test and independent T-test. Results: Analysis showed that there was no significant difference between the test and control groups in terms of demographic characteristics (P > 0.05). Also, There was no significant difference in anxiety score between two groups before intervention (P = 0.81). But significant difference was seen between two groups after intervention using independent T-test (P = 0.001). Pair T-test showed a significant difference in the anxiety reduction in the test group after the intervention (P = 0.001), whereas the same test showed no significant difference in the control group (P = 0.30). Conclusions: Applying partnership care model can reduce level of anxiety in adolescent with β-thalassemia. Therefore, it is recommended to use this model to reduce anxiety in adolescent with β-thalassemia and adolescents with chronic diseases.